BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26476892)

  • 41. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
    Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First-trimester Ultrasound and Aneuploidy Screening in Multifetal Pregnancies.
    Hirshberg A; Dugoff L
    Clin Obstet Gynecol; 2015 Sep; 58(3):559-73. PubMed ID: 26133496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation.
    Hsu JJ; Hsieh CC; Chiang CH; Lo LM; Hsieh TT
    Chang Gung Med J; 2003 Jan; 26(1):12-9. PubMed ID: 12656304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of quality of nuchal translucency measurements: its role in prenatal diagnosis.
    Gabriel CC; Echevarria M; Rodríguez I; Serra B
    ScientificWorldJournal; 2012; 2012():482832. PubMed ID: 22649294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accuracy of nuchal translucency measurement depends on equipment used and its calibration.
    Axell RG; Gillett A; Pasupathy D; Chudleigh T; Brockelsby J; White PA; Lees CC
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):31-7. PubMed ID: 24448754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First-trimester Down syndrome screening: component analytes and timing for optimal performance.
    Wenstrom KD
    Semin Perinatol; 2005 Aug; 29(4):195-202. PubMed ID: 16104668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visualization of intracranial translucency at the 11-13-week scan is improved after specific training.
    Mangione R; Lelong N; Fontanges M; Amat S; Rosenblatt J; Khoshnood B; Jouannic JM
    Ultrasound Obstet Gynecol; 2011 Dec; 38(6):635-9. PubMed ID: 21998023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment.
    Orlandi F; Bilardo CM; Campogrande M; Krantz D; Hallahan T; Rossi C; Viora E
    Ultrasound Obstet Gynecol; 2003 Jul; 22(1):36-9. PubMed ID: 12858300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do Early Fetal Measurements and Nuchal Translucency Correlate With Term Birth Weight?
    Hackmon R; Librach C; Burwick R; Rodrigues N; Farine D; Berger H
    J Obstet Gynaecol Can; 2017 Sep; 39(9):750-756. PubMed ID: 28733063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
    Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fetal nasal bone assessment in first trimester down syndrome screening.
    Has R; Kalelioglu I; Yuksel A; Ibrahimoglu L; Ermis H; Yildirim A
    Fetal Diagn Ther; 2008; 24(1):61-6. PubMed ID: 18504384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frontonasal facial angle in chromosomally normal fetuses at 11+0 to 13+6 weeks.
    Vicario R; Pirollo LM; De Angelis C; Narcisi M; Pietropolli A; Piccione E
    J Obstet Gynaecol Res; 2010 Dec; 36(6):1179-84. PubMed ID: 21040200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture.
    Sahota DS; Leung TY; Chen M; Chan LW; Fung TY; Lau TK
    Ultrasound Obstet Gynecol; 2010 Jul; 36(1):15-9. PubMed ID: 20503228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First-trimester ultrasound examination and the outcome of monochorionic twin pregnancies.
    El Kateb A; Nasr B; Nassar M; Bernard JP; Ville Y
    Prenat Diagn; 2007 Oct; 27(10):922-5. PubMed ID: 17590889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of sonographer nuchal translucency measurement performance--central tendency and dispersion.
    Sahota DS; Chen M; Leung TY; Chan LW; Fung TY; Ting YH; Lau TK
    J Matern Fetal Neonatal Med; 2011 Jun; 24(6):812-6. PubMed ID: 21265719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality management of nuchal translucency measurement in residents.
    Frey Tirri B; Troeger C; Holzgreve W; Tercanli S
    Ultraschall Med; 2007 Oct; 28(5):484-8. PubMed ID: 17918045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Nuchal translucency: this is not so simple!].
    Constant M
    Gynecol Obstet Fertil; 2014 Dec; 42(12):820-1. PubMed ID: 25456489
    [No Abstract]   [Full Text] [Related]  

  • 59. Nuchal translucency and first trimester risk assessment: a systematic review.
    Sheppard C; Platt LD
    Ultrasound Q; 2007 Jun; 23(2):107-16. PubMed ID: 17538486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors influencing visualization of the intracranial translucency during first-trimester screening for aneuploidy.
    Beamon CJ; Stuebe AM; Wolfe HM
    Am J Perinatol; 2012 Aug; 29(7):503-8. PubMed ID: 22495902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.